 3  6 
(CAT) v12 32 and SPM12 (www.fil.ac.uk/spm) to perform voxel-based morphometry (VBM). 1 3 5
This included correcting the bias-field distortions and noise removal, skull stripping, 1 3 6 normalization to standard space and brain tissue segmentation into grey matter, white matter, and 1 3 7 cerebrospinal fluid. Grey matter segments were modulated to represent actual gray matter 1 3 8 volume. We then performed a biologically informed compression of the VBM data to 637 gray 1 3 9 matter parcels based existing in-vivo brain parcellation 33 , 34 . Thus, grey matter volume of each 1 4 0 participant was represented by 637 features each representing an individual parcel volume of that 1 4 1 participant. All consecutive analyses were performed on this data. 1 4 2 1 4 3
Statistical analysis of gray matter volume 1 4 4
Statistical analysis of gray matter volume of parcels included three consecutive parts, 1 4 5 similar to approach used by Bludau et. al 35 ; generating reference statistics, permuted statistics, 1 4 6 and a family-wise error (FWE) correction for multiple comparisons. Here we used an n-way 1 4 7 analysis of variance, to test effect of age, cognitive status (AD/MCI/HC), SDB status and SDB-1 4 8 by-cognitive status interaction, separately as independent variables (factors), on gray matter 1 4 9 volume of each parcel as dependent variable. The F values (per parcel) of this ANOVA were 1 5 0 considered as the reference statistics. In the subsequent permutation statistics for each factor, we 1 5 1 randomly shuffled the labels for that factor 10,000 times, replicated the analysis and recorded the 1 5 2 F-values to build a null-distribution. The comparison of the reference statistic with this 1 5 3 distribution then allows non-parametric inference per parcel and factor, yielding uncorrected p-1 5 4 values. Importantly, however, we also recorded, per replication of the permutation, the highest 1 5 5 statistics in the random data across the entire set, i.e., 637 brain regions, building a null-1 5 6 well as similar numbers across age-brackets and a maximum of 30 subjects per age-bracket and 1 6 8 sex per site. The actual subjects sampled in each replication from the overall database were 1 6 9 drawn from the pool independently at random without replacement. Each of these sampled sets 1 7 0 was then used to fit an individual SVM providing a weak learner for the ensemble which was 1 7 1 applied to the test-data, i.e., the ADNI sample. The process was repeated 10,000 times, yielding 1 7 2 10,000 age predictions based on models trained on (different) balanced subsamples of the multi-1 7 3 cohort reference data. These predictions were then averaged ("bagging") to yield the final age 1 7 4 prediction based on the 637-parcel representation of the VBM data 41 . Each subjects BrainAGE 1 7 5 score was finally calculated as bagged predicted age minus chronological age for each subject Both SDB+ and SDB-groups comprised of 24 AD, 111 MCI, and 30 HC participants, 1 7 9 respectively. As enforced through the matching, there was no statistically significant difference 1 8 0 in demographic variables, cognitive status, and presence of the ApoE4 allele between SDB 1 8 1 groups. Table 1 summarizes the characteristics of all study groups. 1 8 2
Effects on grey matter volume 1 8 3
As noted in the methods, association of parcel-wise gray matter volume with age, 1 8 4 cognitive status, SDB status, and SDB-by-cognitive status interaction was assessed using non-1 8 5 parametric inference with FWE correction for multiple comparisons. There were strong (P FWE 1 8 6 <0.001) and widespread negative associations of regional grey matter volume with age, in 1 8 7 particular in the bilateral temporal lobes, bilateral prefrontal, middle and superior frontal areas, 1 8 8 bilateral medial and lateral occipital areas, cerebellum and thalamus, caudate and putamen in the 1 8 9 subcortical gray matter ( Figure 2A ). The cognitive status was significantly associated with 1 9 0 reduced gray matter volume in many bilateral parcels with dominancy in the left hemisphere 1 9 1 (P FWE <0.001). Bilateral temporal lobes including fusiform gyri, medial temporal lobes and 1 9 2 hippocampal formations, and inferior and middle temporal lobes had significantly lower volume 1 9 3 in participants with MCI and particularly AD. Moreover, reduced gray matter volume was seen 1 9 4 in bilateral insula, middle frontal, and cingulate cortices, as well as left superior frontal cortex 1 9 5 ( Figure 2B ). In turn, when testing for effects of SDB status and SDB-by-cognitive status 1 9 6 interaction, we found no significant regions anywhere in the brain (all P FWE > 0.05). 1 9 7
Effects on estimated brain age 1 9 8 1 1
The mean absolute error between predicted and chronological age in the HC group was 1 9 9
3.59 years, indicative of the very good performance of the ensemble prediction model. We then 2 0 0 calculated the BrainAGE score as the per-subject difference between predicted and chronological 2 0 1 age and tested for its association with cognitive status, SDB status, and the SDB-by-cognitive 2 0 2 status interaction. As it is shown in Figure 3 , participants with MCI and in particular AD showed 2 0 3 an advanced brain age (on average 4.0 and 9.1 years, respectively), in line with previous studies. 2 0 4
However, there was no significant effect on BrainAGE scores associated with SDB status, nor 2 0 5 was there a positive SDB-by-cognitive status interaction suggesting that SDB may not lead to 2 0 6 advanced brain aging ( Figure 3C ). Our findings confirmed previously reported gray matter atrophy and accelerated 2 0 9 biological brain aging in patients with MCI and AD, corroborating the robustness and validity of 2 1 0 our analytical approach. Importantly, we were not able to demonstrate any effect of SDB, 2 1 1 independently or in interaction with cognitive status, on either regional grey matter volume or 2 1 2 brain aging score. Several limitations however, may compromise the interpretation of our results. 2 1 3
Sample sizes of SDB+ subjects in the HC and AD groups were small. Moreover, the groups were 2 1 4 heterogeneous in terms of clinical characteristics and imaging specifications. We used 2 1 5
propensity-score matching and stratified subsampling of external datasets to minimize the effects 2 1 6 of heterogeneity. As previously mentioned on publications using the ADNI database 7,42 , the self-2 1 7
reported measure of SDB can be influenced by both the recall bias of cognitively impaired 2 1 8 subjects as well as by a high prevalence of undiagnosed OSA in the general population, therefore 2 1 9 increasing the probability of false negative cases in the SDB-groups 7 . Moreover, assessment of 2 2 0 the severity of SDB and disease duration were not available. 2 2 1 Grey matter volume alterations in AD and SDB 2 2 2
One of the main characteristics of MCI and AD is generalized gray matter loss in the 2 2 3 brain, which mostly starts in the medial temporal lobe and multimodal association areas 8-10 . 2 2 4
Neuroimaging meta-analyses have demonstrated atrophy in the medial temporal lobe, limbic 2 2 5 regions (left parahippocampl gyrus, left posterior cingulate gyrus, amygdala and uncus), 2 2 6 thalamus, temporal, parietal, frontal and cingulate cortices 43,44 . A similar but milder distribution 2 2 7 of gray matter atrophy is evident in brain of patients with MCI 43,45 . In accordance with the 2 2 8 previous brain volumetric studies, we found diffuse gray matter loss in MCI and AD. The 2 2 9 1 3 atrophy was mainly located in the bilateral temporal lobe and medial temporal areas with higher 2 3 0 intensity in AD compared to MCI. 2 3 1
Assessing the volumetric changes due to SDB, we did not observe any significant 2 3 2 alteration in gray matter volume, neither in HC subjects, nor in patients with MCI or AD. 2 3 3 Furthermore, self-reported SDB interaction with cognitive status (i.e. HC, MCI or AD) showed 2 3 4 no associations with gray matter volume. Historically, there has been an inability to replicate 2 3 5 results among the brain imaging studies of SDB in non-demented populations. While several 2 3 6 studies have reported gray matter atrophy in the insula, amygdala, middle and lateral temporal 2 3 7 regions, and cerebellum in non-demented populations with SDB 13-16,46-48 , others have either 2 3 8
shown no associations 17,49 or paradoxical enhancement in the gray matter volume of regions like 2 3 9 the motor cortices, prefrontal cortex, thalamus, putamen, and the hippocampus 20-24,47 . In 2 4 0 addition, there is a general lack of longitudinal studies, which would enable the study of non-2 4 1 linear associations between SDB and cortical atrophy as suggested by these cross-sectional 2 4 2 findings. Despite these important gaps in the literature, three meta-analyses have concluded that 2 4 3 OSA is associated with gray matter atrophy in a few selected regions including the cingulate, 2 4 4 amygdala, hippocampus, right central insula, right middle temporal gyrus, right premotor cortex, 2 4 5 and cerebellum 13,50,51 . 2 4 6
The observed null association between SDB and gray matter volume should however be 2 4 7 interpreted with caution. First, it has been suggested that aging may have partially protective 2 4 8 mechanisms against SDB, such as reduced production of oxidative stress after apneas and 2 4 9 1 5 excessive neuronal synaptic activity 62 in SDB, all of which could potentially lead to an increase 2 7 6 in beta-amyloid deposition and its clearance reduction. It is therefore possible that the presence 2 7 7 of SDB is associated with AD risk only through beta-amyloid deposition 42,58 or altered brain 2 7 8 function 63-65 , but an interaction should have been observed in MCI or AD where it is generally 2 7 9 accepted that neuronal loss follows amyloid deposition. More studies are needed to better 2 8 0 understand the compensatory increase in gray matter volume in SDB suggested by several 2 8 1 studies, as well as the precise progression of brain atrophy in AD, as both may have contributed 2 8 2 to obtaining such negative findings. BrainAGE prediction in AD and SDB 2 8 5
Brain age prediction methods have been used in cognitively normal subjects 26,66 and 2 8 6 several studies have used the ADNI dataset with mean absolute error (MAE) ranging from 3 to 6 2 8 7 years 25, 27 . We implemented an advanced sensitive BrainAGE estimation method to detect 2 8 8 pathologic brain aging, using repeated SVM models fitted on parcel-wise gray matter volume 2 8 9 data of on stratified subsamples from external cohorts, making the model less sensitive to 2 9 0 heterogeneity in images 25 . Compared to previous studies, while using multiple datasets for 2 9 1 training prediction model, our age prediction results were accurate with an MAE of 3.6 years in 2 9 2
HCs. Replication of previous findings in AD, taken together with acceptable MAE, is indicative 2 9 3 of reliability of our proposed method in gray matter volume assessment and age estimation 2 9 4
While there is no exact definition for accelerated brain aging, BrainAGE score has been 2 9 5
shown to be a sensitive predictor of disease progression in dementia 27-29 . Previous findings on 2 9 6 increased BrainAGE score in MCI and AD course 67-69 , are in agreement with the reported 2 9 7 accelerated aging of the demented brain shown in-vivo and ex-vivo studies 70 . The BrainAGE 2 9 8 1 6 score in studies using ADNI ranged from almost zero for patients with stable MCI, to 5.7-6.2 2 9 9 years for patients with progressive MCI, and reached up to 10 years for patients with AD 27 . We 3 0 0 found the average 4.1 and 9 BrainAGE scores in patients with AD and MCI, in agreement to 3 0 1 previous findings using ADNI data. Since we did not distinguish patients with progressive from 3 0 2 stable MCI, our results in the MCI group were modest compared to other studies including 3 0 3 patients with late or progressive MCI. 3 0 4
Conclusions 3 0 5
In summary, we have confirmed the acceleration of brain atrophy and advanced brain 3 0 6 aging in MCI and AD participants from the ADNI cohort compared to healthy controls. We 3 0 7
further found that self-reported SDB in subjects with a diagnosis of HC, MCI or AD was neither 3 0 8 associated with gray matter volume reduction, nor with accelerated brain aging. While SDB is 3 0 9
suggested to propagate the aging process, amyloid burden and cognitive decline to AD, it may 3 1 0 not necessarily associate to brain atrophy and the estimated brain age in AD progession. 
A2.
Similar pre-processing steps were done on T1 brain images of study-specific SDB+ and SDB-subjects (Study-specific images). Parcel-based results were used in two parallel analyses;
1) C. inputted to partial ANOVA tests for gray matter volume assessment according to presence of SDB and cognitive status as contrasts and 2) D. Decomposed with an OPNMF approach and inputted in the age prediction SVM model developed on the training images.
Figure 2.
Association between volumetric data of cortical and subcortical parcels and age and cognitive status of subjects. Gray matter volume differences in 600 cortical parcels and 37 subcortical volume was assessed using three steps of using F value of an n-way analysis of variance as reference statistics, running 10,000 permutations per randomly shuffling different parcels, under assumption of label exchangeability, and correction of p values using family wise error (FWE) method. Significant parcels are illustrated as the heated areas on the brain maps considering (A) age and (B) cognitive status. Since there were no significant results regarding SDB presence or SDB-by-diagnosis interaction, results according these factors have not been illustrated here. images in the AD, MCI and HC groups. There is an evident higher predicted age for the participants AD and MCI compared to HC group, in accordance with advanced pathological
